Annual Current Ratio
4.13
-2.46-37.33%
31 December 2023
Summary:
Inhibikase Therapeutics annual current ratio is currently 4.13, with the most recent change of -2.46 (-37.33%) on 31 December 2023. During the last 3 years, it has risen by +1.00 (+31.95%). IKT annual current ratio is now -60.55% below its all-time high of 10.47, reached on 31 December 2021.IKT Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
0.85
-1.47-63.36%
30 September 2024
Summary:
Inhibikase Therapeutics quarterly current ratio is currently 0.85, with the most recent change of -1.47 (-63.36%) on 30 September 2024. Over the past year, it has dropped by -5.55 (-86.72%). IKT quarterly current ratio is now -96.70% below its all-time high of 25.73, reached on 30 June 2021.IKT Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.3% | -86.7% |
| 3 y3 years | +31.9% | -95.0% |
| 5 y5 years | +1080.0% | - |
IKT Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.5% | +31.9% | -95.0% | at low |
| 5 y | 5 years | -60.5% | >+9999.0% | -96.7% | +8400.0% |
| alltime | all time | -60.5% | >+9999.0% | -96.7% | +8400.0% |
Inhibikase Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 0.85(-63.4%) |
| June 2024 | - | 2.32(-9.0%) |
| Mar 2024 | - | 2.55(-38.3%) |
| Dec 2023 | 4.13(-37.3%) | 4.13(-35.5%) |
| Sept 2023 | - | 6.40(-20.4%) |
| June 2023 | - | 8.04(-22.5%) |
| Mar 2023 | - | 10.37(+57.4%) |
| Dec 2022 | 6.59 | 6.59(-24.3%) |
| Sept 2022 | - | 8.71(+15.2%) |
| June 2022 | - | 7.56(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 8.76(-16.3%) |
| Dec 2021 | 10.47(+234.5%) | 10.47(-38.2%) |
| Sept 2021 | - | 16.94(-34.2%) |
| June 2021 | - | 25.73(+677.3%) |
| Mar 2021 | - | 3.31(+5.8%) |
| Dec 2020 | 3.13(>+9900.0%) | 3.13(>+9900.0%) |
| Sept 2020 | - | 0.01(0.0%) |
| June 2020 | - | 0.01(0.0%) |
| Mar 2020 | - | 0.01(0.0%) |
| Dec 2019 | 0.01(-97.1%) | 0.01 |
| Dec 2018 | 0.35 | - |
FAQ
- What is Inhibikase Therapeutics annual current ratio?
- What is the all time high annual current ratio for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual current ratio year-on-year change?
- What is Inhibikase Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly current ratio year-on-year change?
What is Inhibikase Therapeutics annual current ratio?
The current annual current ratio of IKT is 4.13
What is the all time high annual current ratio for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual current ratio is 10.47
What is Inhibikase Therapeutics annual current ratio year-on-year change?
Over the past year, IKT annual current ratio has changed by -2.46 (-37.33%)
What is Inhibikase Therapeutics quarterly current ratio?
The current quarterly current ratio of IKT is 0.85
What is the all time high quarterly current ratio for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly current ratio is 25.73
What is Inhibikase Therapeutics quarterly current ratio year-on-year change?
Over the past year, IKT quarterly current ratio has changed by -5.55 (-86.72%)